Metraipolis › archive › dc_baf0837d69cf

Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation — Europe PMC PMID:42688114

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42688114
DOI
10.3389/fphar.2026.1835602
License (as archived)
solo-consultazione
Archived
2026-10-08T07:59:56.359Z
SHA-256 of the archived text
fab9b381758b50a4fe95bdcd182db116c0cf13c00979c870c4897e808e764cd4
Stable URL of this page
https://metraipolis.com/documento/dc_baf0837d69cf

How to cite

Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation — Europe PMC PMID:42688114 — Europe PMC (en), https://europepmc.org/article/MED/42688114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_baf0837d69cf (Metraipolis archive dc_baf0837d69cf, sha256 fab9b381758b50a4fe95bdcd182db116c0cf13c00979c870c4897e808e764cd4)
BibTeX
@misc{dcbaf0837d69cf,
  title = {Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation — Europe PMC PMID:42688114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42688114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_baf0837d69cf; sha256 fab9b381758b50a4fe95bdcd182db116c0cf13c00979c870c4897e808e764cd4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42688114. Agents can read the archived copy with the MCP tool read_document.